Skip to main content
SpringerLink
Log in

Hospital Costs of Total Hip Arthroplasty for Developmental Dysplasia of the Hip

  • Clinical Research
  • Published:
Clinical Orthopaedics and Related Research®

Abstract

Background

Developmental dysplasia of the hip (DDH) is a leading cause of total hip arthroplasty (THA) in younger patients. It is unknown how the hospital costs of THA in patients with DDH compare with patients with degenerative arthritis.

Questions/purposes

We undertook this study to determine (1) the hospital cost and length of stay associated with primary THA in patients with dysplasia compared with nondysplastic control subjects; (2) the hospital cost and length of stay of THA in severely dysplastic hips compared with mildly dysplastic hips; and (3) perioperative complications in patients with DDH compared with patients without dysplasia.

Methods

This matched-cohort study included 354 patients undergoing primary THA for DDH and 1029 age-, sex-, and calendar year-matched patients undergoing THA for primary osteoarthritis between 2000 and 2008. DDH severity was measured by the Crowe classification. An institutional database was used to calculate the cost of care. Using line item details (date, type, frequency, and billed charge) for every procedure or service billed at our institution for each patient, bottom-up microcosting valuation techniques were used to generate standardized inflation-adjusted estimates of the cost of each service or procedure in constant dollars. Generalized linear random effects models were used to compare length of stay and costs during hospitalization and the 90-day period after surgery. Query of a longitudinal institutional database was used to identify documented complications.

Results

Patients with DDH undergoing primary THA incurred higher hospital costs than patients with primary osteoarthritis (USD 16,949 versus USD 16,485, p = 0.012). Operating room costs (USD 3471 versus USD 3417, p = 0.0085) and implant costs (USD 3896 versus USD 3493, p < 0.001) were higher in the DDH group compared with the osteoarthritis group. Length of stay was not different between the two groups (4 versus 4 days, p = 0.46). Crowe 4 hips had higher hospital costs than Crowe 1 hips (USD 21,246 versus USD 16,345, p < 0.001) with an associated longer length of stay (5 days versus 4 days, p = 0.0011) and higher implant costs (USD 4380 versus USD 3788, p = 0.0012). There was no detectible difference in 90-day complications in the case group compared with patients undergoing THA for osteoarthritis.

Conclusions

Hospital cost of primary THA is approximately USD 450 higher in patients with DDH compared with osteoarthritis. Increased severity of dysplasia (Crowe classification) was associated with higher costs.

Level of Evidence

Level IV, economic and decision analyses. See Guidelines for Authors for a complete description of levels of evidence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Boyle MJ, Frampton CM, Crawford HA. Early results of total hip arthroplasty in patients with developmental dysplasia of the hip compared with patients with osteoarthritis. J Arthroplasty. 2012;27:386–390.

    Article  PubMed  Google Scholar 

  2. Boyle MJ, Singleton N, Frampton CM, Muir D. Functional response to total hip arthroplasty in patients with hip dysplasia. ANZ J Surg. 2013;83:554–558.

    Article  PubMed  Google Scholar 

  3. Bozic KJ, Morshed S, Silverstein MD, Rubash HE, Kahn JG. Use of cost-effectiveness analysis to evaluate new technologies in orthopaedics. The case of alternative bearing surfaces in total hip arthroplasty. J Bone Joint Surg Am. 2006;88:706–714.

    Article  PubMed  Google Scholar 

  4. Crowe JF, Mani VJ, Ranawat CS. Total hip replacement in congenital dislocation and dysplasia of the hip. J Bone Joint Surg Am. 1979;61:15–23.

    CAS  PubMed  Google Scholar 

  5. Daigle ME, Weinstein AM, Katz JN, Losina E. The cost-effectiveness of total joint arthroplasty: a systematic review of published literature. Best Pract Res Clin Rheumatol. 2012;26:649–658.

    Article  PubMed  Google Scholar 

  6. Dreghorn CR, Roughneen P, Graham J, Hamblen DL. The real cost of joint replacement. Br Med J (Clin Res Ed). 1986;292:1636–1637.

    Article  CAS  Google Scholar 

  7. Edlin R, Tubeuf S, Achten J, Parsons N, Costa M. Cost-effectiveness of total hip arthroplasty versus resurfacing arthroplasty: economic evaluation alongside a clinical trial. BMJ Open. 2012;2. pii: e001162.

  8. Engesaeter IO, Lehmann T, Laborie LB, Lie SA, Rosendahl K, Engesaeter LB. Total hip replacement in young adults with hip dysplasia: age at diagnosis, previous treatment, quality of life, and validation of diagnoses reported to the Norwegian Arthroplasty Register between 1987 and 2007. Acta Orthop. 2011;82:149–154.

    Article  PubMed Central  PubMed  Google Scholar 

  9. Felson DT, Zhang Y. An update on the epidemiology of knee and hip osteoarthritis with a view to prevention. Arthritis Rheum. 1998;41:1343–1355.

    Article  CAS  PubMed  Google Scholar 

  10. Gent E, Clarke NM. Joint replacement for sequelae of childhood hip disorders. J Pediatr Orthop. 2004;24:235–240.

    Article  PubMed  Google Scholar 

  11. Gioe TJ, Sharma A, Tatman P, Mehle S. Do ‘premium’ joint implants add value? Analysis of high cost joint implants in a community registry. Clin Orthop Relat Res. 2011;469:48–54.

    Article  PubMed Central  PubMed  Google Scholar 

  12. Harris WH. Etiology of osteoarthritis of the hip. Clin Orthop Relat Res. 1986;213:20–33.

    PubMed  Google Scholar 

  13. Hawker GA, Badley EM, Croxford R, Coyte PC, Glazier RH, Guan J, Harvey BJ, Williams JI, Wright JG. A population-based nested case–control study of the costs of hip and knee replacement surgery. Med Care. 2009;47:732–741.

    Article  PubMed  Google Scholar 

  14. Holman J, Carroll KL, Murray KA, Macleod LM, Roach JW. Long-term follow-up of open reduction surgery for developmental dislocation of the hip. J Pediatr Orthop. 2012;32:121–124.

    Article  PubMed  Google Scholar 

  15. Kelly MP, Bozic KJ. Cost drivers in total hip arthroplasty: effects of procedure volume and implant selling price. Am J Orthop (Belle Mead NJ). 2009;38:E1–4.

    PubMed  Google Scholar 

  16. Kim S. Changes in surgical loads and economic burden of hip and knee replacements in the US: 1997–2004. Arthritis Rheum. 2008;59:481–488.

    Article  PubMed  Google Scholar 

  17. Krych AJ, Howard JL, Trousdale RT, Cabanela ME, Berry DJ. Total hip arthroplasty with shortening subtrochanteric osteotomy in Crowe type-IV developmental dysplasia. J Bone Joint Surg Am. 2009;91:2213–2221.

    Article  PubMed  Google Scholar 

  18. Lei P, Hu Y, Cai P, Xie J, Yang X, Wang L. Greater trochanter osteotomy with cementless THA for Crowe type IV DDH. Orthopedics. 2013;36:e601–605.

    Article  PubMed  Google Scholar 

  19. Mahan ST, Katz JN, Kim YJ. To screen or not to screen? A decision analysis of the utility of screening for developmental dysplasia of the hip. J Bone Joint Surg Am. 2009;91:1705–1719.

    Article  PubMed Central  PubMed  Google Scholar 

  20. Maradit Kremers H, Visscher SL, Moriarty JP, Reinalda MS, Kremers WK, Naessens JM, Lewallen DG. Determinants of direct medical costs in primary and revision total knee arthroplasty. Clin Orthop Relat Res. 2013;471:206–214.

    Google Scholar 

  21. March L, Cross M, Tribe K, Lapsley H, Courtenay B, Brooks P. Cost of joint replacement surgery for osteoarthritis: the patients’ perspective. J Rheumatol. 2002;29:1006–1014.

    PubMed  Google Scholar 

  22. Meyers SJ, Reuben JD, Cox DD, Watson M. Inpatient cost of primary total joint arthroplasty. J Arthroplasty. 1996;11:281–285.

    Article  CAS  PubMed  Google Scholar 

  23. Noordin S, Umer M, Hafeez K, Nawaz H. Developmental dysplasia of the hip. Orthop Rev (Pavia). 2010;2:e19.

    PubMed Central  PubMed  Google Scholar 

  24. Orszag PR, Ellis P. The challenge of rising health care costs–a view from the Congressional Budget Office. N Engl J Med. 2007;357:1793–1795.

    Article  CAS  PubMed  Google Scholar 

  25. Reuben JD, Meyers SJ, Cox DD, Elliott M, Watson M, Shim SD. Cost comparison between bilateral simultaneous, staged, and unilateral total joint arthroplasty. J Arthroplasty. 1998;13:172–179.

    Article  CAS  PubMed  Google Scholar 

  26. Stargardt T. Health service costs in Europe: cost and reimbursement of primary hip replacement in nine countries. Health Econ. 2008;17:S9–20.

    Article  PubMed  Google Scholar 

  27. Takenaga RK, Callaghan JJ, Bedard NA, Liu SS, Klaassen AL, Pedersen DR. Cementless total hip arthroplasty in patients fifty years of age or younger: a minimum ten-year follow-up. J Bone Joint Surg Am. 2012;94:2153–2159.

    Article  PubMed  Google Scholar 

  28. Tamegai H, Otani T, Fujii H, Kawaguchi Y, Hayama T, Marumo K. A modified S-ROM stem in primary total hip arthroplasty for developmental dysplasia of the hip. J Arthroplasty. 2013;28:1741–1745.

    Article  PubMed  Google Scholar 

  29. Tellini A, Ciccone V, Blonna D, Rossi R, Marmotti A, Castoldi F. Quality of life evaluation in patients affected by osteoarthritis secondary to congenital hip dysplasia after total hip replacement. J Orthop Traumatol. 2008;9:155–158.

    Article  PubMed Central  PubMed  Google Scholar 

  30. Terjesen T, Bredland T, Berg V. Ultrasound for hip assessment in the newborn. J Bone Joint Surg Br. 1989;71:767–773.

    CAS  PubMed  Google Scholar 

  31. Terjesen T, Holen KJ, Tegnander A. Hip abnormalities detected by ultrasound in clinically normal newborn infants. J Bone Joint Surg Br. 1996;78:636–640.

    CAS  PubMed  Google Scholar 

  32. Thillemann TM, Pedersen AB, Johnsen SP, Soballe K. Implant survival after primary total hip arthroplasty due to childhood hip disorders: results from the Danish Hip Arthroplasty Registry. Acta Orthop. 2008;79:769–776.

    Article  PubMed  Google Scholar 

  33. Wedge JH, Wasylenko MJ. The natural history of congenital dislocation of the hip: a critical review. Clin Orthop Relat Res. 1978;137:154–162.

    PubMed  Google Scholar 

  34. Yan F, Chen G, Yang L, He R, Gu L, Wang F. A reduction technique of arthroplasty without subtrochanteric femoral shortening osteotomy for the treatment of developmental high dislocation of hip: a case series of 28 hips. J Arthroplasty. 2013 Dec 4 [Epub ahead of print].

  35. Yang S, Cui Q. Total hip arthroplasty in developmental dysplasia of the hip: review of anatomy, techniques and outcomes. World J Orthop. 2012;3:42–48.

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Orthopedic Surgery, Mayo Clinic, 200 1st Street SW, Rochester, MN, 55905, USA

    Ali Ashraf MD, A. Noelle Larson MD, Hilal Maradit-Kremers MD, MSc & David G. Lewallen MD

  2. Department of Health Science Research, Mayo Clinic, Rochester, MN, USA

    Hilal Maradit-Kremers MD, MSc & Walter K. Kremers PhD

Authors
  1. Ali Ashraf MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Noelle Larson MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hilal Maradit-Kremers MD, MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Walter K. Kremers PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. David G. Lewallen MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Noelle Larson MD.

Additional information

One of the authors (DGL) receives between USD 10,000 and USD 100,000 including royalties from Zimmer, Warsaw, IN, USA; personal fees and other from Pipeline Biomedical Holdings, Cedar Knolls, NJ, USA; and Ketai Medical Devices, Hong Kong (stock and paid consultant) outside the submitted work.

All ICMJE Conflict of Interest Forms for authors and Clinical Orthopaedics and Related Research editors and board members are on file with the publication and can be viewed on request.

Each author certifies that his or her institution approved the human protocol for this investigation, that all investigations were conducted in conformity with ethical principles of research, and that informed consent for participation in the study was obtained.

About this article

Cite this article

Ashraf, A., Larson, A.N., Maradit-Kremers, H. et al. Hospital Costs of Total Hip Arthroplasty for Developmental Dysplasia of the Hip. Clin Orthop Relat Res 472, 2237–2244 (2014). https://doi.org/10.1007/s11999-014-3587-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11999-014-3587-9

Keywords

Search

Navigation